Michal Bassani-Sternberg
@michal_bassani
Group leader, Immunopeptidomics, immunotherapy and cancer antigen discovery.
ID: 980535736435970048
01-04-2018 20:01:51
537 Tweet
1,1K Followers
713 Following
💡NEW STUDY about #NeoDisc: a cutting-edge tool for neoantigen discovery in personalized cancer #immunotherapy in Nature Biotechnology by Michal Bassani-Sternberg Florian Huber et al. Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois Université de Lausanne 🔗 nature.com/articles/s4158… ▶️news.unil.ch/display/172863…
Thank you Nature Biotechnology for the great overview on NeoDisc in the Research briefing nature.com/articles/s4158…
Scientists led by Ludwig Oncology UNIL CHUV's Florian Huber & Michal Bassani-Sternberg report NeoDisc, a computational pipeline that integrates molecular/genetic analyses of tumors + targets of T cells and harnesses AI to design personalized cancer vaccines. bit.ly/4eFqe59
New online in Nature Biotechnology by Michal Bassani-Sternberg group: The neoantigen discovery pipeline NeoDisk incorporates mass spectrometry immunopeptidomics data. Florian Huber Oncology UNIL CHUV Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois SIB
Michal Bassani-Sternberg Florian Huber Oncology UNIL CHUV Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois SIB Research Briefing: An antigen discovery pipeline integrates multi-omics data and informs immunotherapy go.nature.com/3Y96wrp
Wow, NeoDisc is an amazing pipeline that characterizes neoantigens, TAAs, TSAs, viral antigens, and antigen presentation defects with genomic, transcriptomic, immunopeptidomic data. It includes TE expression 🤯! Congrats to the pioneer Michal Bassani-Sternberg, Florian Huber , and team!
Michal Bassani-Sternberg Florian Huber Oncology UNIL CHUV Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois SIB NeoDisc pipeline enables personalised cancer immunotherapy #NBTintheNews via World Vaccine Congress vaccinenation.org/technology/neo…
Mass Spectrometry / Major Histocompatibility Complex: Cheryl Lichti, Yifat Merbl, and Michal Bassani Sternberg addressed this topic in a plenary session at the AACR Special Conference on Tumor Immunology and Immunotherapy. #AACRtii24 Yifat Merbl lab Michal Bassani-Sternberg
Huber et al. developed a pipeline (Neodisc) integrating WGS/WES, RNAseq, and immunopeptidomics to predict and prioritize antigenic peptides derived from mutations, TSAs, TAAs, oncoviruses, or [...] bit.ly/3YywYvP Florian Huber Oncology UNIL CHUV Michal Bassani-Sternberg
![Huber et al. developed a pipeline (Neodisc) integrating WGS/WES, RNAseq, and immunopeptidomics to predict and prioritize antigenic peptides derived from mutations, TSAs, TAAs, oncoviruses, or [...] bit.ly/3YywYvP <a href="/FlorianHuber_/">Florian Huber</a> <a href="/OncoUNILCHUV/">Oncology UNIL CHUV</a> <a href="/michal_bassani/">Michal Bassani-Sternberg</a>](https://pbs.twimg.com/media/Galqc9YXYAAEnzJ.jpg "ACIR (@acir_org) on Twitter photo Huber et al. developed a pipeline (Neodisc) integrating WGS/WES, RNAseq, and immunopeptidomics to predict and prioritize antigenic peptides derived from mutations, TSAs, TAAs, oncoviruses, or [...] bit.ly/3YywYvP <a href=\"/FlorianHuber_/\">Florian Huber</a> <a href=\"/OncoUNILCHUV/\">Oncology UNIL CHUV</a> <a href=\"/michal_bassani/\">Michal Bassani-Sternberg</a>")
Discover what's in store for Immuno-Oncology and Technology! Watch our video to learn about our article types, the submission process, and what you can expect as an author or reader. Find out more spkl.io/6018fOAbi ESMO IOTECH
💡NEW STUDY published in #PNAS by Melita Irving and Greta M P. Giordano Attianese introducing dual ON/OFF-switch #CAR-T cells, offering a safer, more flexible approach to cancer #immunotherapy. 🔗pnas.org/doi/10.1073/pn… @ludwig_cancer Université de Lausanne Faculté de biologie et de médecine (inactif) CHUV / Centre hospitalier universitaire vaudois EPFL
